Comparative study of the effect of intranasal insulin on memory deficits in type 2 diabetes and early Alzheimer´s dementia (INSULA)

Trial Profile

Comparative study of the effect of intranasal insulin on memory deficits in type 2 diabetes and early Alzheimer´s dementia (INSULA)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Insulin aspart (Primary)
  • Indications Alzheimer's disease; Mild cognitive impairment; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms INSULA
  • Most Recent Events

    • 09 Mar 2016 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
    • 23 May 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2008-008555-41).
    • 15 Nov 2012 Status changed from planning to recruiting as reported by German Clinical Trials Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top